Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clinical Trials Need Peer Review To Qualify For Medicare Funds - AHRQ Panel

This article was originally published in The Gray Sheet

Executive Summary

Clinical trials seeking Medicare reimbursement of routine care costs should first undergo an external scientific review, according to a multi-agency panel convened by the Agency for Healthcare Research & Quality.

You may also be interested in...



HHS IG Notice On Clinical Trials Coverage Overlooks Private Studies

Possible exceptions to federal civil money penalties associated with Medicare fraud and abuse over clinical trial participation "inducements" are being sought by the HHS Office of the Inspector General

HHS IG Notice On Clinical Trials Coverage Overlooks Private Studies

Possible exceptions to federal civil money penalties associated with Medicare fraud and abuse over clinical trial participation "inducements" are being sought by the HHS Office of the Inspector General

Medicare Coverage Appeals Regulation Remains Distant Goal For CMS

Establishing an appeals process for local and national coverage decisions has been relegated to CMS' list of "long-term" goals, according to the 1HHS semiannual regulatory plan, released Dec. 3

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014948

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel